title: The management of 138 psoriatic arthritic patients.
abstract: Clinical experience obtained in the management of 138 patients of psoriatic arthritis is reported. The correct recognition of arthritic subtype (according to Moll and Wright classification) always resulted essentially in the choice of the therapy. Our programme included rehabilitative, pharmacologic and surgical approaches. Our data suggest that psoriatic arthritis is a mild articular disease when compared to other affections such as rheumatoid arthritis or ankylosing spondylitis. Notwithstanding an accurate therapeutical programme, it is necessary to control atypical cases which not infrequently can occur.
authors.affiliation: Rheumatology Unit, 2nd Medical School University of Naples, Italy.
authors.forename: R
authors.initials: R
authors.lastname: Scarpa
authors.forename: A
authors.initials: A
authors.lastname: Pucino
authors.forename: M
authors.initials: M
authors.lastname: Iocco
authors.forename: M
authors.initials: M
authors.lastname: Sollazzo
authors.forename: C
authors.initials: C
authors.lastname: Biondi Oriente
authors.forename: P
authors.initials: P
authors.lastname: Oriente
mesh_terms: D000328:Adult; D000368:Aged; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000627:therapeutic use; D015535:Arthritis, Psoriatic / Q000145:classification / Q000534:rehabilitation / Q000628:therapy*; D005081:Exercise Therapy; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D050607:Organogold Compounds
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D018501:Antirheumatic Agents; D050607:Organogold Compounds